ArticleInternational urology and nephrology2026
Explainable machine learning models for early prediction of acute kidney injury after cardiac surgery.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Machine learning for the prediction of acute kidney injury post cardiac surgery: a systematic review and meta-analysis.BMC medical informatics and decision making · 2026Pooled it
- Multi-Output Machine Learning for Prediction of Postoperative Outcomes After Cardiac Surgery Using Patient Blood Management Biomarkers.Journal of clinical medicine · 2026Article
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
- Commented on by
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
backgroundThis study aimed to develop a data-driven prediction model for cardiac surgery-associated acute kidney injury (CSA-AKI) at the end of surgery using machine learning (ML) algorithms.
methodsWe retrospectively collected clinical data from patients undergoing cardiac surgery at Nanjing First Hospital between June 2016 and January 2023. Feature selection was performed using Lasso regression to identify variables most strongly associated with CSA-AKI. Six ML algorithms-logistic regression (LR), random forest (RF), gradient boosting decision tree (GBDT), eXtreme Gradient Boosting Trees (XGBoost), support vector machine (SVM), and an ensemble model (ENS, integrating GBDT, XGBT, and RF)-were developed and evaluated. External validation was performed on 1,174 patients from the MIMIC-IV database. Model interpretability was assessed via SHAP analysis.
resultsIn this study of 2,277 cardiac surgery patients, the incidence of CSA-AKI was 22.6%. Patients were divided into training (n = 1,593) and internal validation (n = 684) sets, with comparable AKI rates (22.6% vs. 22.5%). An external validation cohort (n = 1,174) showed a higher AKI incidence (86.9%) and differing baseline characteristics. Feature selection via Lasso regression identified 11 key predictors, with intraoperative red blood cell (RBC) transfusion and cardiopulmonary bypass (CPB) time consistently ranking among the top contributors. Six ML models were developed, with the ensemble model achieving the highest AUC (0.856). External validation confirmed model robustness, with SVM performing best (AUC = 0.847). Confusion matrix analysis demonstrated high accuracy across models, and SHAP analysis reinforced the importance of transfusion and CPB time in AKI prediction.
conclusionsML models, particularly the ensemble approach, provide reliable prediction of CSA-AKI, with generalizability validated in an external cohort. These models facilitate early identification of high-risk patients, enabling timely perioperative interventions to improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.